The Beach Boys’ Mike Love returns to the stage despite ‘facing serious health challenges’ - The Guardian
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
After months of cancelled comeback tours, the Beach Boys have played their first public show since July – with co-founder and frontman Mike Love joining the band on stage in Cincinnati, Ohio, despite “facing serious health challenges”. Love was helped on to the stage by his son Christian Love and the actor and band member John Stamos, who told the audience at PNC Pavilion on Saturday night that Love has “been going through some health issues … but he would not miss tonight”. “It’s what he loves the most,” Stamos said before the show. “He loves the audience, he loves the music. He knows how important it is to all of you. So we’re all here to support him and give him as much love as we can.”The 85-year-old musician – who was wearing a cap, hoodie and scarf – remained seated for the performance, with a microphone positioned on a stand before him. He sang back-up vocals and spoke to the audience to thank them for coming to the show. On Sunday night, Stamos shared an emotional message on Instagram about his “beloved friend, father figure, musical hero and mentor” as the band headed to Nashville, Tennessee, to play at the Ryman Auditorium with Love.
This article is an excerpt. To read the full content, visit the original source. The Guardian
Related articles
European Medical Journal | HIV linked to early signs of heart dysfunction - European AIDS Treatment Group
Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress
Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!